Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Oral Mucositis Companies

Oral mucositis is a common side effect of cancer treatments such as chemotherapy and radiation therapy. It is characterized by inflammation and ulceration of the mucous membranes lining the mouth, leading to pain, difficulty eating, and an increased risk of infection. Several companies are actively involved in developing products and therapies to address oral mucositis.

Oral Mucositis Key Companies

Latest Oral Mucositis Companies Update

OncoMed Announced positive Phase 2b data for navicixumab (OM1901), its investigational monoclonal antibody for the prevention of radiation-induced OM in head and neck cancer patients.

Soligenix Launched NeuMucof-G, a topical oral rinse for the management of OM in head and neck cancer patients. This marks the company's first commercialization of an OM product.

OraPharma Received FDA Fast Track designation for OP01501, its topical mucosal protectant for the prevention of OM in patients undergoing hematopoietic stem cell transplantation.

EUSA Pharma Successfully completed the Phase 2 clinical trial of palifermin oral rinse for the prevention of OM in patients undergoing stem cell transplantation. Further development plans are underway.

Innovation Pharmaceuticals Partnered with Aizano Medical Technology to develop and commercialize the Aizano Oral Mucositis Relief System, a non-drug device for OM management.

List of Oral Mucositis Key Companies in the Market

Izun Pharmaceuticals Corporation

Shoreline Pharmaceuticals Inc

AMAG Pharmaceutical Inc

Innovation Pharmaceuticals

Himalaya Drug Company

Oral Mucositis Market Highlights:

Oral Mucositis Market Size

Oral Mucositis Market Trends

Oral Mucositis Market Analysis

Oral Mucositis Market Share

Oral Mucositis Market Highlights:

Oral Mucositis Market Trends

Oral Mucositis Market Analysis

Oral Mucositis Market Share

Oral Mucositis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.